TOPICAL SDZ GLC-756, A NOVEL DOPAMINE D-1 ANTAGONIST AND D-2 AGONIST, LOWERS INTRAOCULAR PRESSURE IN CONSCIOUS RABBITS

スポンサーリンク

概要

• 論文の詳細を見る
• 1996-03-01

著者

• Markstein Rudolf

  Novartis Pharma Ag Basel Che

• PRUNTE Christian

  University Eye Clinic

• NUTTLI Ines

  Preclinical Research, Sandoz Pharma, Ltd

• MARKSTEIN Rudolf

  Preclinical Research, Sandoz Pharma, Ltd

• Nuttli Ines

  Preclinical Research Sandoz Pharma Ltd

関連論文

• Antiglaucoma Drug GLC756 and Its Effect on Cellular cAMP and Tumor Necrosis Factor α Release In Vitro of Activated Human Monocytic Leukemia Cells
• The Influence of Sex Difference in Measurements with the Langham Ocular Blood Flow System
• TOPICAL SDZ GLC-756, A NOVEL DOPAMINE D-1 ANTAGONIST AND D-2 AGONIST, LOWERS INTRAOCULAR PRESSURE IN CONSCIOUS RABBITS

スポンサーリンク